TOUS - ETF AI Analysis
Top Page
T. Rowe Price International Equity ETF (TOUS)
Rating:64Neutral
Price Target:―
Positive Factors
Strong Overall Year-To-Date Performance
The fund has delivered strong gains so far this year, showing solid momentum in its international stock picks.
Leading Holdings With Strong Gains
Several top positions, including ASML, Renesas Electronics, Mitsubishi UFJ Financial Group, Siemens, and TotalEnergies, have shown strong performance, helping drive the ETF’s returns.
Broad International Diversification
The ETF spreads its investments across many countries such as Japan, the UK, the U.S., and several European and Asia-Pacific markets, reducing reliance on any single economy.
Negative Factors
Mixed Performance Among Top Holdings
Some major holdings like AstraZeneca and Unilever have shown weak performance, which can offset gains from stronger stocks in the portfolio.
Moderate Expense Ratio
The fund’s expense ratio is not especially low, meaning investors give up a noticeable portion of returns each year to fees compared with cheaper index ETFs.
Recent Short-Term Weakness
The ETF has shown slightly negative performance over the past month, indicating some short-term volatility that investors should be prepared for.
TOUS vs. SPDR S&P 500 ETF (SPY)
AUM1.59B
RegionDeveloped Markets
Expense Ratio0.50%
Beta0.74
IssuerT. Rowe Price
Inception DateJun 14, 2023
Dividend Yield1.54%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume123,198
30 Day Avg. Volume176,949
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
45.24Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering185
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TOUS Summary
The T. Rowe Price International Equity ETF (TOUS) is an actively managed fund that invests in stocks from many countries outside the U.S., aiming to capture the “total market” of international companies rather than tracking a single index. It holds well-known names like ASML Holding and Unilever, along with banks, industrial firms, health care, and technology companies across Japan, the UK, Europe, and more. Investors might consider TOUS for global diversification and long-term growth potential beyond the U.S. market. A key risk is that international stocks can be volatile and are affected by currency swings, foreign economies, and global market ups and downs.
How much will it cost me?The T. Rowe Price International Equity ETF (TOUS) has an expense ratio of 0.5%, which means you’ll pay $5 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, meaning professional managers are selecting investments rather than tracking a passive index.
What would affect this ETF?The T. Rowe Price International Equity ETF (TOUS) could benefit from growth in developed markets outside the U.S., particularly in sectors like financials, technology, and health care, which make up a significant portion of its holdings. However, potential risks include economic slowdowns in key regions, regulatory changes affecting top holdings like ASML or AstraZeneca, and currency fluctuations that could impact returns for U.S.-based investors. Global interest rate changes and geopolitical tensions may also influence the ETF's performance.
TOUS Top 10 Holdings
TOUS leans heavily on a mix of European and Japanese blue chips, with ASML and Renesas giving the fund much of its tech spark despite some recent wobbling in the near term. Financials are clearly in the driver’s seat: Mitsubishi UFJ, UniCredit, and Barclays have been rising and help anchor performance, while Rolls-Royce and Siemens add an industrial backbone that’s mostly been supportive. On the flip side, AstraZeneca and Unilever have been lagging, showing that not every defensive name in this developed-markets‑ex‑U.S. lineup is pulling its weight.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.52% | $54.64M | €520.34B | 133.80% | 76 Outperform | |
| AstraZeneca | 2.21% | $34.25M | $274.03B | 12.33% | 80 Outperform | |
| Rolls-Royce Holdings | 1.80% | $27.92M | £115.00B | 40.07% | 71 Outperform | |
| UniCredit SpA | 1.68% | $26.14M | €120.29B | 25.39% | 75 Outperform | |
| Unilever | 1.60% | $24.83M | £107.41B | -2.20% | 72 Outperform | |
| Mitsubishi UFJ Financial Group | 1.42% | $22.12M | ¥40.78T | 58.84% | 76 Outperform | |
| Roche Holding AG | 1.42% | $22.06M | $358.16B | 38.89% | 73 Outperform | |
| Siemens | 1.34% | $20.85M | €206.76B | 23.09% | 74 Outperform | |
| TotalEnergies SE | 1.30% | $20.15M | €169.27B | 44.50% | 78 Outperform | |
| Renesas Electronics | 1.30% | $20.12M | ¥5.63T | 77.04% | 64 Neutral |
TOUS Technical Analysis
Positive
―
Price Trends
38.06
Positive
36.93
Positive
35.90
Positive
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TOUS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 38.35, equal to the 50-day MA of 38.06, and equal to the 200-day MA of 35.90, indicating a bullish trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TOUS.
TOUS Peer Comparison
Comparison Results
Performance Comparison
TOUS
T. Rowe Price International Equity ETF
38.91
7.79
25.03%
DIHP
Dimensional International High Profitability ETF
―
―
―
DFIS
Dimensional International Small Cap ETF
―
―
―
CGIE
Capital Group International Equity ETF
―
―
―
SEIE
SEI Select International Equity ETF
―
―
―
DFSI
Dimensional International Sustainability Core 1 ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents